The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000892314
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
2/07/2026
Date registered
Help: Date registered
20/07/2026
Date last updated
Help: Date last updated
21/09/2026
Date data sharing statement initially provided
Help: Data sharing statement date
20/07/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Effects of Clinician- or AI-Delivered Guideline-Concordant Advice on Opioid Use in Acute Low Back Pain: A 2×2 Factorial Randomised Clinical Trial
Scientific title
Effects of Clinician- or AI-Delivered Guideline-Concordant Advice on Opioid Use in Adults who Reported Acute Low Back Pain: A 2×2 Factorial Randomised Clinical Trial
Additional trial identifiers [1] 317004 0
Nil
Additional trial identifiers [2] 318493 0
None.
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Low back pain 342691 0
Opioid use 342692 0
Condition category
Condition code
Musculoskeletal 338833 338833 0 0
Other muscular and skeletal disorders
Mental Health 338931 338931 0 0
Addiction

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Intervention

Participants will be randomly allocated in a 1:1:1:1 ratio to one of four intervention groups. Each participant will receive only one intervention and will view one approximately one minute educational video. Before viewing the video, participants will be asked to read a brief hypothetical scenario describing that they have acute low back pain and are consulting a healthcare professional about pain management. They will then watch the assigned video and complete a post intervention questionnaire assessing their beliefs and intended use of opioids.

The four intervention groups are:

Arm 1: Clinician delivered, "avoid opioids" advice: Participants view a video featuring a real clinician delivering evidence based advice that opioids are not recommended and should be avoided for acute low back pain.

Arm 2: Clinician delivered, "last resort" advice: Participants view a video featuring a real clinician delivering evidence based advice that opioids should only be considered as a last resort for acute low back pain after other recommended treatments have been tried.

Arm 3: AI delivered, "avoid opioids" advice: Participants view a video in which the advice is delivered by an AI generated human avatar with high realism in facial appearance, voice, and movements. The content is identical to Arm 1, recommending that opioids are not recommended and should be avoided for acute low back pain.

Arm 4: AI delivered, "last resort" advice: Participants view a video in which the advice is delivered by an AI generated human avatar with high realism in facial appearance, voice, and movements. The content is identical to Arm 2, recommending that opioids should only be considered as a last resort for acute low back pain.

Intervention content: All four videos were developed specifically for this study and are approximately one minute in duration. The videos communicate guideline concordant advice regarding opioid use for acute low back pain. The advice provided to participants in the video (to avoid opioids where possible, or use them only as a last resort for acute low back pain) is evidence-based, reflecting current international clinical practice guideline recommendations for the management of non-specific low back pain. Participants are not simply told this is "evidence-based" without basis — the advice itself is derived directly from published guideline recommendations. This is supported by the following reference, which provides an overview of global clinical practice guidelines for non-specific low back pain:

Oliveira CB, Koes BW, Pinto RZ, Traeger AC, Machado GC, Lin CC, et al. Towards global clinical practice guidelines for the management of non-specific low back pain in primary care: a review of current guideline recommendations and how they have changed over the last 30 years. Lancet Rheumatol. 2026;8(6):e470-e85. doi: 10.1016/S2665-9913(26)00077-9. PubMed PMID: 42203385.

The only differences between intervention groups are:
1. Mode of delivery: real clinician versus AI generated human avatar.
2. Advice framing: opioids should be avoided versus opioids should only be used as a last resort.

Apart from these two factors, the script, duration, and overall structure of the videos are standardised across all groups.

Total intervention duration: The intervention consists of reading one hypothetical clinical scenario and viewing one approximately one minute educational video. Including the scenario, the intervention takes approximately 2 to 3 minutes to complete. Participants then complete the study questionnaire.

Intervention adherence: Intervention delivery is fully automated within REDCap. Participants must view their allocated video before proceeding to the post intervention questionnaire. REDCap records questionnaire completion and study completion status, allowing monitoring of intervention completion and overall participant adherence.
Intervention code [1] 334626 0
Behaviour
Description of the comparator or control
This study does not include a no intervention, placebo, or usual care control group. For the purposes of the registry, the comparator is arm 1: the clinician delivered advice recommending that opioids should be avoided for acute low back pain.

The comparator consists of an approximately one minute educational video featuring a registered clinician delivering guideline concordant advice that opioids are not recommended and should be avoided for acute low back pain. The video was developed specifically for this study using a standardised script based on current clinical practice guidelines.

Participants first read a brief hypothetical scenario describing that they have acute low back pain and are consulting a healthcare professional about pain management. They then view the allocated comparator video online and subsequently complete the study questionnaire.

The comparator is delivered online as an individual, self administered intervention through the REDCap study platform. Participants complete the intervention remotely using their own internet enabled device at a location of their choice (e.g. home).

The comparator is delivered once during a single study session. The video is approximately one minute in duration, and the total intervention, including reading the hypothetical scenario and viewing the video, takes approximately 2 to 3 minutes.

Adherence is monitored automatically within REDCap. Participants are required to view the allocated video before proceeding to the post intervention questionnaire. REDCap records questionnaire completion and study completion status to monitor intervention completion.
Control group
Active

Outcomes
Primary outcome [1] 346036 0
Intention to take opioid medicines for acute low back pain
Timepoint [1] 346036 0
Immediately after completion of the intervention (within the same online survey)
Secondary outcome [1] 464401 0
Intent to take opioids (Supplementary to the primary outcome)
Timepoint [1] 464401 0
Immediately after completion of the intervention (within the same online survey).
Secondary outcome [2] 464402 0
Intention to stay active
Timepoint [2] 464402 0
Immediately after completion of the intervention (within the same online survey).
Secondary outcome [3] 464405 0
Intention to take non opioid medicines
Timepoint [3] 464405 0
Immediately after completion of the intervention (within the same online survey).
Secondary outcome [4] 464406 0
Overall satisfaction with the advice
Timepoint [4] 464406 0
Immediately after completion of the intervention (within the same online survey).
Secondary outcome [5] 464408 0
Trust in the advice
Timepoint [5] 464408 0
Immediately after completion of the intervention (within the same online survey).
Secondary outcome [6] 464409 0
Confidence in the advice
Timepoint [6] 464409 0
Immediately after completion of the intervention (within the same online survey).

Eligibility
Key inclusion criteria
Eligibility will be assessed using a screening survey in REDCap. Participants will be eligible if they meet all of the following:
• Age 18 years or older
• Self-reported an episode of low back pain either currently or within the previous 3 months
• Individuals who have not sought care for low back pain from a medical practitioner within the past year (“Have you ever seen a doctor for low back pain within the past 1 year?” Yes/No).
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Participants will be excluded if they meet any of the following:
• Insufficient English proficiency to understand trial procedures or complete surveys
• Sign of contraindications to opioid analgesics (“Have you ever been told by a doctor that you should not take opioid pain medications because they could be risky for you?” Yes/No).
• Participants who are planning conception, or are currently pregnant, or breastfeeding

Study design
Purpose of the study
Educational / counselling / training
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation will be conducted automatically through REDCap, and allocation concealment will be maintained using REDCap’s built-in randomisation module.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
computer-generated allocation sequence with fixed permuted blocks of 4
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



The people analysing the results/data
Intervention assignment
Factorial
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
ACT,NSW,NT,QLD,SA,TAS,WA,VIC
Recruitment outside Australia
Country [1] 28284 0
Canada
State/province [1] 28284 0
Country [2] 28285 0
United States of America
State/province [2] 28285 0
Country [3] 28286 0
United Kingdom
State/province [3] 28286 0

Funding & Sponsors
Funding source category [1] 321601 0
Government body
Name [1] 321601 0
Principal Investigator's National Health and Medical Research Council (NHMRC) grant
Country [1] 321601 0
Australia
Primary sponsor type
Individual
Name
Professor Chung Wei Christine Lin, Institute for Musculoskeletal Health, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Australia
Address
Country
Australia
Secondary sponsor category [1] 325248 0
None
Name [1] 325248 0
Address [1] 325248 0
Country [1] 325248 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320127 0
The University of Sydney Human Research Ethics Committee
Ethics committee address [1] 320127 0
Ethics committee country [1] 320127 0
Australia
Date submitted for ethics approval [1] 320127 0
20/04/2026
Approval date [1] 320127 0
23/06/2026
Ethics approval number [1] 320127 0
2026/HE000484

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 149526 0
Prof Chung-Wei Christine Lin
Address 149526 0
Institute for Musculoskeletal Health, 77 Parramatta Road, Camperdown, New South Wales 2050, Australia
Country 149526 0
Australia
Phone 149526 0
+61 2 8627 6237
Fax 149526 0
Email 149526 0
Contact person for public queries
Name 149527 0
Siya Zhao
Address 149527 0
Institute for Musculoskeletal Health, 77 Parramatta Road, Camperdown, New South Wales 2050, Australia
Country 149527 0
Australia
Phone 149527 0
+61424593887
Fax 149527 0
Email 149527 0
Contact person for scientific queries
Name 149528 0
Siya Zhao
Address 149528 0
Institute for Musculoskeletal Health, 77 Parramatta Road, Camperdown, New South Wales 2050, Australia
Country 149528 0
Australia
Phone 149528 0
+61424593887
Fax 149528 0
Email 149528 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: Individual participant data will not be made publicly available because participant consent for public data sharing was not obtained, and data will be reported in aggregate form only.



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
TypeIs Peer Reviewed?DOICitations or Other DetailsAttachment
Statistical analysis planNohttps://doi.org/10.17605/OSF.IO/MWGNJ ACTRN12626000892314_SAP_v1.0_2026-08-21_signed.pdf

Documents added automatically
No additional documents have been identified.